内镜套扎术联合卡维地洛预防食管静脉曲张再出血的效果

Abstract
Figure/Table
References (21)
Related Citation (11)

Download: PDF (947 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the efficacy of endoscopic ligation combined with Carvedilol in the prevention of esophageal varices rebleeding. Methods A total of 126 patients with cirrhosis of esophageal varices treated in Xi'an Central Hospital from October 2016 to June 2017 were enrolled. The patients were divided into experimental group, control group A and control group B by random number table method with 42 cases in each group. The control group A was treated with endoscopic ligation alone. The control group B was treated with endoscopic ligation combined with Propranolol. The experimental group was treated with endoscopic ligation combined with Carvedilol. Oneyear follow-up was performed after operation. Clinical effect, rebleeding rate, Child-Pugh classification of liver function, esophageal varices classification, and spleen hardness were compared before and after treatment. Results The total effective rate of the experimental group was higher than that of the control group A and the control group B (P ＜ 0.05). The rebleeding rate in the experimental group was lower than that in the control group A and the control group B (P ＜ 0.05). One year postoperation, the Child-Pugh classification of liver function in the experimental group was better than that before treatment, and it was better than that in the control group A and the control group B (P ＜ 0.05). The grades of esophageal varices in the three groups all improved than those before treatment, and the experimental group was superior to the control group A and the control group B (P ＜ 0.05). The spleen hardness of the three groups were lower than those before treatment, and the experimental group was lower than that in the control group A and the control group B (P ＜ 0.05). Conclusion Endoscopic ligation combined with Carvedilol treating patients with cirrhosis of esophageal varices can enhance the efficacy, reduce rebleeding, improve liver function and esophageal varices, and reduce spleen stiffness.

Key words： Cirrhosis Esophageal varices Rupture hemorrhage Endoscopic ligation Carvedilol Rebleeding rate Degree of esophageal varices

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YUAN Shanshan ZHANG Xin ZHANG Yanting YANG Zhenwei TANG Hailing LI Yijun ZHUANG Kun

Cite this article:

YUAN Shanshan ZHANG Xin ZHANG Yanting YANG Zhenwei TANG Hailing LI Yijun ZHUANG Kun. Efficacy of endoscopic ligation combined with Carvedilol for prevention of esophageal varices rebleeding[J]. 中国医药导报, 2018, 15(35): 134-137,145.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I35/134

[1] Men C，Zhang G. Endoscopic ultrasonography predicts early esophageal variceal bleeding in liver cirrhosis：A case report [J]. Medicine，2017，96（17）：e6749.
[2] 崔星亮，任海霞，王建华，等.超声下胃左静脉指标在肝硬化食管静脉曲张破裂出血预测中的应用[J].山东医药，2014，54（14）：55-57.
[3] 刘浩雷，燕晟，刘瑛，等.卡维地洛联合内镜套扎术预防食管静脉曲张再次出血的疗效及安全性分析[J].中国内镜杂志，2015，21（2）：132-135.
[4] 朱庆曦，田霞，刘蒙，等.内镜下套扎联合组织胶注射治疗食管静脉曲张破裂出血的临床疗效[J].世界华人消化杂志，2016，24（13）：2045-2050.
[5] 冯瑞兵.内镜下套扎术联合β-受体阻滞剂预防肝硬化食管静脉曲张再出血的Meta分析[J].中国医药导报，2015， 12（2）：74-78.
[6] 刘晓.内镜下套扎术联合药物治疗食管静脉曲张出血临床疗效观察[J].实用医院临床杂志，2016，13（5）：182-184.
[7] 钟媚，张冰，李秀媚.NSBB在预防食管静脉曲张内镜套扎术后早期再出血的意义[J].实用药物与临床，2016，19（1）：113-116.
[8] 谢俊锋，顾秋平，朱方擎，等.卡维地洛对肝硬化食管胃静脉曲张再出血的预防作用[J].中国现代医生，2017，55（36）：35-37.
[9] Sauerbruch T，Mengel M，Dollinger M，et al. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy [J]. Gastroenterology，2015，149（3）：660-668.
[10] 赵丽，付立英.预前护理对肝硬化食管静脉曲张破裂出血的影响[J].河北医药，2014，36（2）：291-293.
[11] 石兵，蒋雨卉，吕琳，等.内镜与药物治疗肝硬化伴食管静脉曲张破裂出血的疗效比较[J].现代生物医学进展，2016，16（12）：2309-2311.
[12] 庞美志，何咖鲒.内镜下套扎术联合硬化剂注射术治疗食管静脉曲张破裂出血的疗效观察[J].广西医学，2014， 36（7）：983-985.
[13] 蔡升，周建波，桑建忠，等.食管静脉曲张破裂出血内镜下套扎、硬化剂注射及序贯联合治疗的对比研究[J].浙江医学，2017，39（7）：555-558.
[14] 叶营，孙相钊，蔡春调，等.内镜联合药物诊治肝硬化食管胃底静脉曲张破裂出血的疗效及再出血危险因素研究[J].海南医学，2017，28（3）：374-378.
[15] 李莉，陈洁，刘春燕，等.内镜下套扎术联合药物治疗食管静脉曲张出血的效果[J].中国医药导报，2014，11（17）：31-33.
[16] 韩静，柳喜凤，刘四方，等.内镜下硬化治疗后联合普萘洛尔、螺内酯预防食管静脉曲张再出血的疗效观察[J].河北医科大学学报，2015，36（8）：942-943.
[17] 王传芳，樊丽娟.内镜治疗后口服卡维地洛预防肝硬化食管静脉曲张破裂出血患者再出血的效果分析[J].中国中西医结合消化杂志，2017，25（10）：755-758.
[18] 柳金金，贾继东.卡维地洛对肝硬化食管静脉曲张出血的预防作用[J].肝脏，2014，19（1）：63-64.
[19] 张冬琴，吴吉圆，龚作炯.卡维地洛对肝硬化门静脉高压食管胃静脉曲张出血的防治作用研究进展[J].实用肝脏病杂志，2016，19（4）：509-512.
[20] 盛竹鸽，王莹，朱浪潮，等.卡维地洛或普萘洛尔联合内镜下套扎治疗肝硬化合并食管静脉曲张出血的疗效观察[J].现代消化及介入诊疗，2017，22（1）：56-58.
[21] 郭芸蕾，鲁晓岚，程妍，等.肝脾硬度联合门静脉宽度评估肝硬化食管胃底静脉曲张出血风险[J].中华肝脏病杂志，2016，24（1）：56-61.